60 Degrees Pharmaceuticals, Inc. (SXTPW) stock
SXTPWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 8/3033% below fair value
$0.03−0.00 (-0.38%)
Close on Oct 30, 2026Market cap $3.31MP/E –Yield –
60 Degrees Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
60 Degrees Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.77M. For fiscal 2025 it was -$6.85M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.85M | – |
| FY2024 | Dec 31, 2024 | -$5.65M | – |
| FY2023 | Dec 31, 2023 | -$4.54M | – |
| FY2022 | Dec 31, 2022 | -$1.01M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.23M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.74M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.11M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.68M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.14M | – |
| Q4 FY2023 | Dec 31, 2023 | -$63.67K | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.75M | – |
| Q2 FY2023 | Jun 30, 2023 | -$313.49K | – |
| Q1 FY2023 | Mar 31, 2023 | -$412.68K | – |
| Q4 FY2022 | Dec 31, 2022 | -$65.98K | – |
| Q3 FY2022 | Sep 30, 2022 | -$307.06K | – |